New pill aims to tame stubborn high blood pressure
NCT ID NCT07489612
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new daily pill called QLS1410 in 260 adults whose high blood pressure remains high despite taking two or more medications. Participants will receive either QLS1410 or a placebo for 12 weeks. The main goal is to see if QLS1410 can lower systolic blood pressure more than placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QLS1410 tablet
- What this could lead to
- If it works, this could provide a new daily pill option for people whose high blood pressure is not controlled by current medications.
- What could go wrong
- This is an early Phase 2 trial with only 260 participants, so results may not apply to everyone. The drug is still experimental and may not lower blood pressure better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
Jinan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Partner-Powered program tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- Can a lifestyle coach lower your risk of stroke and dementia?
- Remote care may cut stroke risk — a small trial puts it to the test
- Nurse-Led mobile clinics aim to tame high blood pressure in liberia
- Drug duo aims to tackle high blood pressure in obesity